PALO ALTO, Calif., March 20, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical corporate enthusiastic about growing drugs for genetic prerequisites, as of late introduced that on March 18, 2026, the reimbursement committee of BridgeBio’s board of administrators licensed fairness grants to 29 new staff in limited inventory gadgets for an mixture of 70,916 stocks of the Corporate’s commonplace inventory. One-fourth of the stocks underlying every worker’s limited inventory gadgets will vest on February 16, 2027, with one-twelfth of the rest stocks underlying every such worker’s limited inventory gadgets vesting on a quarterly foundation thereafter, in every case, topic to every such worker’s endured employment with the Corporate or one among its subsidiaries on such vesting dates.
The above-described awards had been every granted as an inducement subject matter to the workers coming into into employment with the Corporate in line with Nasdaq List Rule 5635(c)(4) and had been granted pursuant to the phrases of the Plan. The Plan used to be followed via BridgeBio’s board of administrators in November 2019, and amended and restated on February 10, 2023 and on December 13, 2023.
About BridgeBio Pharma, Inc.BridgeBio exists to increase transformative drugs for genetic prerequisites. Thousands and thousands of other people international residing with genetic prerequisites lack remedy choices, incessantly as a result of drug building for small affected person populations will also be commercially difficult. We intention to bridge the distance between developments in genetic science and significant drugs for underserved affected person populations. Our decentralized, hub-and-spoke type is designed for pace, precision, and scalability. Self sufficient and empowered groups focal point on particular person prerequisites, whilst a central hub supplies the scientific, regulatory, and business functions had to deliver innovation to marketplace. For more info, discuss with bridgebio.com and apply us on LinkedIn, X, Fb, Instagram, YouTube, and TikTok.
